MAPT and Alzheimer disease: Misfolded deposits of the amyloid beta peptide (Aβ)1,2 and the microtubule-associated protein tau (MAPT)3 are pivotal pathological features in Alzheimer’s disease (AD), wherein reduced brain regional glucose metabolism and synaptic density are correlated with the development of clinical cognitive dysfunction4.